Form D · Biotechnology
Codagenix Inc.
Farmingdale, NY · CIK 0001967165
Offering snapshot reported Feb 27, 2023 · SEC filing
- Reported sold
- $25M Offering amount: $25M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 10, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 27, 2023 | Initial | $25,005,232 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-474366
Source: Form D, filed Feb 27, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Robert Coleman | Director, Executive |
| Tyler Cook | Executive |
| Paul Grint | Director |
| Jill Howe | Director |
| Steffen Mueller | Director |
| Charlie Petty | Director |
| Glenn Rockman | Director |
| Lori Rudolph Owen | Director |
| Steven Winick | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3 Bioscience Park Dr.
Farmingdale, NY, 11735
Farmingdale, NY, 11735